Tucci Marco

24PUBLICATIONS
119CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 28, 2025
Immunotherapy in Advanced Cutaneous Melanoma: From the Optimal Treatment Duration to the Impact on Survival in Case of Early Discontinuation Due to Immune-Related Adverse Events.

Giacomo Triggiano, Gaetano Pezzicoli, Marco Tucci

|Dec 17, 2024
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.

Francesca Consoli, Marco Tucci, Jacopo Pigozzo

|Jan 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.

Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca

|May 27, 2023
Checkpoint Inhibitor-Induced Colitis: An Update.

Giuseppe Losurdo, Daniele Angelillo, Nicolas Favia

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Mar 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.

Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta

Pageof 4

Frequent Collaborators

4 joint publications

Francesco Mannavola

4 joint publications

Maria Chiara Sergi

4 joint publications

Valeria Internò

3 joint publications

Mauro Cives